Table 2.
Accuracy in human CSF for sex steroid hormones.
| Spiked pg/mL | Baseline pg/mL | Measured pg/mL | Accuracy % | ||
|---|---|---|---|---|---|
| DHT | Low level | 1.5 | 0 | 1.50 | 100 |
| High level | 40 | 1.77 | 44.1 | 106 | |
| Testosterone | Low level | 7.5 | 1.53 | 9.62 | 108 |
| High level | 200 | 26.5 | 228 | 101 | |
| E1 | Low level | 0.6 | 0.82 | 1.31 | 83 |
| High level | 16 | 2.42 | 17.9 | 97 | |
| E2 | Low level | 0.3 | 0 | 0.36 | 120 |
| High level | 16 | 0 | 17.5 | 109 | |
| DHEA | Low level | 7.5 | 38.4 | 44.9 | 87 |
| High level | 400 | 91.8 | 456 | 91 | |
| 4D | Low level | 100 | 52.3 | 156 | 104 |
| High level | 250 | 52.3 | 312 | 104 | |
| P | Low level | 3.75 | 0 | 4.23 | 113 |
| High level | 15 | 0 | 15.7 | 105 |
Accuracies were calculated as (measured level − baseline level)/spiked level × 100. Five replicates for each level evaluated were used for the accuracy determinations. Part of the validation data for testosterone have previously been published (16).
4D, androstenedione; DHEA, dehydroepiandrosterone; DHT, dihydrotestosterone; E1, estrone; E2, estradiol; P, progesterone.
This work is licensed under a